TransCode Therapeutics, Inc., (RNAZ): Price and Financial Metrics

TransCode Therapeutics, Inc., (RNAZ): $10.36

0.30 (-2.81%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add RNAZ to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#246 of 337

in industry

RNAZ Price/Volume Stats

Current price $10.36 52-week high $66.33
Prev. close $10.66 52-week low $2.66
Day low $10.10 Volume 134,700
Day high $10.56 Avg. volume 3,291,350
50-day MA $6.32 Dividend yield N/A
200-day MA $17.84 Market Cap 7.21M

RNAZ Stock Price Chart Interactive Chart >


TransCode Therapeutics, Inc., (RNAZ) Company Bio


TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs for the treatment of metastatic diseases. The company's lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. Its products in discovery and preclinical stage include MicroRNA-10b, TTX-siPDL1, TTX-siLIN28b, and TTX-RIGA, which focuses on treating various cancers. The company was incorporated in 2016 and is based in Boston, Massachusetts.


RNAZ Latest News Stream


Event/Time News Detail
Loading, please wait...

RNAZ Latest Social Stream


Loading social stream, please wait...

View Full RNAZ Social Stream

RNAZ Price Returns

1-mo 209.25%
3-mo -4.87%
6-mo 14.16%
1-year -53.76%
3-year -99.98%
5-year N/A
YTD 207.42%
2024 -98.45%
2023 -98.78%
2022 -73.50%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!